2020
DOI: 10.4088/jcp.19r12965
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Effects of Intrauterine Exposure to Antidepressants on Physical, Neurodevelopmental, and Psychiatric Outcomes:

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
36
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 37 publications
(37 citation statements)
references
References 0 publications
1
36
0
Order By: Relevance
“…Most studies on antidepressant treatment during pregnancy have so far centered on potential negative childhood outcomes, e.g., congenital malformations, neonatal persistent pulmonary hypertension, and neurodevelopment and psychiatric outcomes [6,7,34]. In contrast, the effectiveness of antidepressants in preventing psychiatric emergencies during pregnancy has not…”
Section: Antidepressant Discontinuation During Pregnancy and Psychiatric Emergency Riskmentioning
confidence: 99%
See 1 more Smart Citation
“…Most studies on antidepressant treatment during pregnancy have so far centered on potential negative childhood outcomes, e.g., congenital malformations, neonatal persistent pulmonary hypertension, and neurodevelopment and psychiatric outcomes [6,7,34]. In contrast, the effectiveness of antidepressants in preventing psychiatric emergencies during pregnancy has not…”
Section: Antidepressant Discontinuation During Pregnancy and Psychiatric Emergency Riskmentioning
confidence: 99%
“…Similarly, antidepressant use during pregnancy is common: Approximately 2% to 8% of pregnant women in Europe [4] and 8% to 13% in the United States of America [5] receive antidepressant prescriptions at some point in their pregnancy. However, concerns have been raised about offspring sequelae of in utero antidepressant exposure [6,7], and, consequently, more than 50% of women discontinue antidepressants during pregnancy [8].…”
Section: Introductionmentioning
confidence: 99%
“…Such prenatal exposure has been associated with an increased risk for altered motor, social‐emotional, language, and cognitive development from infancy to childhood (Brown et al., 2016; Hanley et al., 2013, 2015; Oberlander et al., 2008; Weikum et al., 2012, 2013; Zeskind & Stephens, 2004), as well as affective disorders in adolescence (X. Liu et al., 2017; Malm et al., 2016). However, not all studies are converging (Hermansen & Melinder, 2015) and long‐term physical, neurodevelopmental, and psychiatric outcomes appear to be driven, at least in part, by the underlying maternal mood disorder (Rommel et al., 2020).…”
Section: Introductionmentioning
confidence: 99%
“…Our review of rodent studies suggests that results from perinatal exposure to both SSRIs and other common antidepressants may more consistently increase depressive-like, but not anxious behaviors, in offspring. Among studies of outcomes in humans, the majority of studies suggest that prenatal SSRI exposure does not increase risk for internalizing and anxious behaviors in young children, especially when maternal mood is controlled for using stringent analytic approaches (Rommel et al, 2020). Moreover, to date research studying SSRI exposure and depressive behaviors remains limited and needs increased attention.…”
Section: Future Directions and Conclusionmentioning
confidence: 99%